Phase 2 Data for Mesothelioma Drug Shows Potential

According to a story from pm360online.com, the clinical stage corporation Epizyme recently released detailed results from the Phase 2 trial of its leading investigational candidate, tazemetostat. This drug is in…

Continue Reading Phase 2 Data for Mesothelioma Drug Shows Potential

PBCers 2018 Conference Wrap Up

The PBCers Biannual Conference recently took place in Houston, Texas. The 2018 PBCers Conference was highly informative with topics ranging from the basics of Primary Biliary Cholangitis, dietary tips, updates…

Continue Reading PBCers 2018 Conference Wrap Up